title: [Therapy of lymphogranulomatosis].
abstract: A survey is given on the therapy of lymphogranulomatosis. Keystones of the treatment are radiotherapy, antineoplastic chemotherapy and supportive measures of treatment. A therapy referred to diagnosis and stages including a clinical and pathological staging proves to be necessary in every case. The initial treatment consists in a radiotherapy in the stages I, II and III A, in a polychemotherapy according to the scheme MOPP and COPP, respectively, or CVPP in the stages III B and IV as well as possibly in a combined treatment in histomorphologically unfavourable forms also already in the early stages. The problems of the MOPP alternative programmes in primary failures, of the programmes of the post-MOPP-therapy in secondary failures and recidivations as well as of the remission-keeping long-term therapy need a further clarification. It is referred to the dangers and side-effects of an aggressive radio- and chemotherapy.
mesh_terms: D003037:Cobalt Radioisotopes; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D009150:Mustard Compounds / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D003037:Cobalt Radioisotopes; D009150:Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D011239:Prednisolone
vernacular_title: Die Therapie der Lymphogranulomatose.